---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-106654"
form_type: "8-K"
ticker: "SSII"
cik: "0001676163"
company_name: "SS Innovations International, Inc."
filed_at: "2026-10-05T12:00:49+00:00"
generated_at: "2026-10-12T14:44:43.025979+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# SS Innovations furnishes October 2026 investor deck; excerpt shows no financial figures or guidance

## Summary
- SS Innovations International, Inc. (Nasdaq: SSII) furnished an updated October 2026 Company Presentation for use in shareholder and investor communications.
- The exhibit text provided contains only the title slide, which describes the company as building "Advanced, Affordable and Accessible Surgical Robotic Solutions."
- No revenue, EPS, procedure volumes, product milestones, guidance, deal terms, or financing details appear in the filing or the excerpted exhibit, so no substantive new operating data can be reported.
- Company is chaired by Sudhir Srivastava, M.D., who is also CEO; principal offices are in Gurugram, Haryana, India; the 8-K is dated October 5, 2026.

## SEC filing metadata
- accession: 0001213900-26-106654
- form_type: 8-K
- ticker: SSII
- cik: 0001676163
- company_name: SS Innovations International, Inc.
- filed_at: 2026-10-05T12:00:49+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676163/000121390026106654/0001213900-26-106654-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676163/000121390026106654/ea0307579-8k_ssinnova.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-106654
- JSON: https://secwatch.observer/filing/0001213900-26-106654.json
- Plain text: https://secwatch.observer/filing/0001213900-26-106654.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.